Submissions

Author Guidelines

1. Scope and Editorial Policy

JBBI publishes high-quality research in biochemistry, molecular biology, biophysics, nanomedicine, antimicrobial peptides, targeted drug delivery systems, and plant-derived functional therapeutics.

• Peer review: single-blind. Every manuscript is evaluated by two external, independent peer reviewers. Authors are not informed of the reviewers' identities.
• Publication frequency: annual, with rolling online ahead-of-print publication.
• Plagiarism policy: JBBI uses Turnitin. A maximum similarity index of 19% is permitted, with no more than 3–4% from a single source.
• Fees: no submission or article processing charges.

2. Article Categories

Editorials

Written by the Editor-in-Chief, invited guest editors, or members of the editorial board. Editorials discuss overarching themes of current journal issues, highlight breakthrough discoveries in biochemistry and nanomedicine, or outline journal policies and future directions.

• Word count: 1,000–2,000 words
• References: up to 15
• Peer review: evaluated by the Editor-in-Chief

Original Research Articles

Full-length, comprehensive reports of original empirical investigations in biochemistry, molecular biology, biophysics, nanomedicine, antimicrobial peptides, and plant-derived functional therapeutics. Work must be methodologically sound and contribute novel data to the field.

• Word count: 4,000–7,000 words (excluding abstract, references, and figure legends)
• Structure: structured abstract (Background, Methods, Results, Conclusions), Introduction, Materials and Methods, Results and Discussion, Conclusions, and References
• Peer review: single-blind, by at least two independent expert reviewers

Review Articles and Systematic Reviews

Critical, in-depth summaries of current literature and recent advancements in specific, high-interest biochemical or biomedical domains. Systematic reviews must follow standard reporting guidelines (e.g., PRISMA).

• Word count: 6,000–10,000 words
• Structure: unstructured abstract, comprehensive introduction, thematic body paragraphs, future perspectives, and conclusions
• Peer review: single-blind

Short Communications / Technical Notes

Concise reports detailing preliminary yet significant research findings, novel methodological techniques, software tools in computational biochemistry (such as advanced AutoDock Vina protocols), or rapid breakthroughs that warrant immediate dissemination.

• Word count: 2,000–3,000 words (maximum 3 tables/figures)
• Peer review: single-blind

Letters to the Editor and Commentaries

Constructive critiques, discussions, or analytical responses regarding articles previously published in JBBI, or brief academic opinions on emerging topics in the biomedical sciences. Authors of the original article may be invited to write a formal reply.

• Word count: 800–1,500 words
• References: up to 10
• Peer review: evaluated by the Editorial Board

Case Reports / Clinical Biochemistry Notes

Unique clinical case studies highlighting rare biochemical disorders, atypical metabolic presentations, or novel diagnostic approaches in clinical biochemistry and pathology.

• Word count: 2,000–3,500 words
• Structure: Abstract, Introduction, Case Presentation, Discussion, and Patient Consent statement
• Peer review: single-blind

3. General Formatting and Layout

• File format: Microsoft Word (.doc or .docx)
• Page setup: A4 size with 1-inch (2.54 cm) margins on all sides
• Font and size: Times New Roman, 12-point
• Line spacing: double-spaced throughout (including abstract, text, figure captions, and references)
• Page and line numbering: continuous line numbering and page numbers must be enabled throughout the document to assist reviewers

4. Structure of the Manuscript (Original Research)

A. Title Page (separate file or first page)

• Title: concise, specific, and informative (avoid abbreviations)
• Author information: full names, academic titles/affiliations (Department, University, City, Country), and the corresponding author's official email address
• ORCID iDs: mandatory for the corresponding author and strongly encouraged for all co-authors

B. Main Document

• Abstract: a structured summary of 250–300 words comprising Background, Objectives, Methods, Results, and Conclusions, with 4–6 keywords (avoiding words already in the title)
• Introduction: background of the research, existing gaps in literature, and the explicit hypothesis or objective of the study
• Materials and Methods: detailed description of experimental procedures, ethical approvals (for animal/human studies), statistical analyses, and computational tools (e.g., AutoDock Vina parameters for molecular docking) to ensure reproducibility
• Results and Discussion: clear and cohesive presentation of experimental findings, supported by tables and figures where appropriate, with interpretation of results in the context of existing scientific literature, emphasizing the implications of the findings and study limitations
• Conclusions: a concise summary of the primary findings and future perspectives
• Declarations: ethics approval and consent to participate (if applicable); competing interests (authors must declare any financial or personal conflicts of interest); author contributions using the CRediT taxonomy (e.g., Conceptualization, Methodology, Writing – Original Draft)
• References: formatted according to the style below

5. Tables and Figures

• Tables: must be created using Microsoft Word's table feature (do not insert as images). Number sequentially (Table 1, Table 2) with brief, descriptive titles placed above the table.
• Figures: high-resolution images (PNG or JPEG at minimum 300 DPI). Number sequentially (Figure 1, Figure 2) with captions placed below the figure. Ensure all axis labels, text, and molecular structures are legible.

6. Reference Style (APA 7th Edition)

References must be cited in-text by author surname and year (e.g., Ansari et al., 2025) and listed alphabetically in the References section.

Journal article:
Ansari, A. M., Khan, S., & Abro, M. (2025). Nanoscale drug delivery systems in targeted biotherapy. Journal of Biochemistry and Biomedical Innovations, 1(1), 45–58. https://doi.org/10.xxxx/jbbi.2025.123

Book:
Nelson, D. L., & Cox, M. M. (2021). Lehninger Principles of Biochemistry (8th ed.). W. H. Freeman.